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BACKGROUND: There are only a few studies that have investigated inflammatory processes during ovarian
hyperstimulation, with contradictory results especially concerning outcome. The aim of the study was to investigate
the inflammatory markers C-reactive protein and leptin in serum and follicular fluid and to correlate these with
the outcome. METHODS: One hundred and sixty-two gonadotrophin stimulated cycles were evaluated. Serum
concentrations of leptin and C-reactive protein were measured at the initiation of stimulation, on the day of hCG
administration or the day before, and on the day of oocyte retrieval. They were also determined in the follicular
fluid. RESULTS: Serum leptin and C-reactive protein levels increased significantly during stimulation until the
day of oocyte pick up, but following different patterns. After stimulation, they correlated with each other in serum
and follicular fluid, but not with estradiol or progesterone concentration, embryo quality, or the pregnancy rate.
CONCLUSIONS: Leptin and C-reactive protein levels change significantly during assisted reproductive treatment.
In contrast to estradiol they are, however, not a marker of success.
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Introduction
Leptin, the hormone encoded by the obesity (ob) gene and
initally found to have anti-obesity properties, has since been
shown to be proinflammatory (Janik et al., 1997), immuno-
regulatory (Lord et al., 1998) and angiogenic (Lord et al.,
1998; Sierra-Honigmann et al., 1998). It influences reproduc-
tion (Masuzaki et al., 1997) and may be involved in the
pathogenesis of endometriosis (Matarese et al., 2000) and
infertility (Barash et al., 1996; Brzechffa et al., 1996). Leptin
was found in oocytes and follicular fluid (FF) (Karlsson et al.,
1997), but its production by granulosa cells is a conflicting
issue. Cioffi et al. found leptin expression at the mRNA and
protein levels by granulosa and cumulus cells and the pre-
sence of leptin in mature human oocytes (Cioffi et al., 1997);
so did Loeffler et al. (2001). Karlsson et al., however,
reported the absence of ob gene expression in human granu-
losa cells (Karlsson et al., 1997) and Karamouti et al. con-
firmed their findings, demonstrating that leptin is not secreted
by human luteinized granulosa cells in cultures (Karamouti
et al., 2003). Lower mean follicular fluid and serum leptin
concentrations were suggested to be associated with an
increased pregnancy rate in some studies (Mantzoros et al.,
2000; Tsai et al., 2002). Welt et al. (2003) have not seen any
association of follicular fluid leptin concentrations with
oocyte quality, fertilization or embryo grade in contrast to
Barroso et al. (1999), where leptin follicular fluid levels
correlated negatively with embryo quality. Concentrations of
circulating leptin are increased by inflammatory mediators
(Saraff et al., 1997).
C-reactive protein (CRP) is an acute phase protein and is
produced by the liver. Several studies have found that body
mass index (BMI) is strongly associated not only with leptin
but also with CRP levels (Mendall et al., 1996; Ford, 1999;
Visser et al., 1999; Yudkin et al., 1999). CRP was found to be
increased after estrogen administration (Kluft et al., 2002).
An association between plasma CRP and leptin has been
shown in humans (Shamsuzzaman et al., 2004) and Bullo
et al. even demonstrated that leptin could induce the pro-
duction of CRP (Bullo et al., 2003). Maruna et al. identified
leptin as an acute phase reactant with potential haemato-
poietic, immunomodulatory and hepatocyte stimulating
activity and also found a significant correlation between CRP
and leptin (Maruna et al., 2001). The available results on the
usefulness of CRP concentrations as a marker of success in
assisted reproductive technologies (ART) are controversial. In
the study of Sacks et al., CRP levels have been measured
before IVF stimulation and 14 days after egg collection.
Women pregnant after IVF, especially pregnant women after
ovarian hyperstimulation had significantly higher CRP levels
compared to non-pregnant women 14 days after egg collection
(Sacks et al., 2004). Almagor et al. found serum CRP levels,
measured on the day of embryo transfer to be correlated with
the outcome of in vitro fertilization (IVF)-treatment (Almagor
et al., 2004), while Orvieto et al. (2004a) did not.
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Ovulation is an inflammatory process, and the interactions
and correlations of leptin and CRP are thus of great interest
in this context. To our knowledge only a few studies on CRP
in assisted reproduction, and no data comparing CRP with
leptin and steroids in this field, are available in the literature.
The aim of the present study was to examine whether lep-
tin and CRP, which are both involved in inflammatory pro-
cesses, are correlated with each other and whether they could
be an outcome marker in IVF treatment.
Materials and methods
Patients and IVF procedure
The present study contains serum and follicular fluid from 162
women undergoing IVF with intracytoplasmic sperm injection
(ICSI). Inclusion criteria were a patient age of 42 years maximum,
normal pre-treatment hormonal values, gynecological ultrasound
results and cervical smears. Criteria for exclusion from an
IVF/ICSI-treatment were acute or chronic infectious diseases, severe
psychiatric problems, or being a carrier of severe genetic diseases.
Written consent for the treatment by IVF/ICSI was given by all
patients, and the investigation was approved by the ethical commit-
tee of the University of Berne.
For ovarian stimulation, the ‘long’ protocol was used. With the
agonist Triptorelin, 0.1 mg per day s.c. (Decapeptylw, Ferring phar-
maceuticals, Wallisellen, Switzerland), downregulation was per-
formed either in the luteal phase of the previous or on the first day
of the treatment cycle until complete pituitary desensitization was
documented. After sonographic evidence indicated no ovarian fol-
licular activity and serum levels of human chorionic gonadotrophin
(hCG) and estradiol were below 2 mIU/ml and 130 pmol/l, respect-
ively, stimulation was initiated in most cases with recombinant FSH
(Gonal-Fw, Serono Pharma, Geneva, Switzerland or Puregonw,
Organon Pharmaceuticals, Pfa¨ffikon, Switzerland) or with menopau-
sal gonadotrophin (hMG, Pergonalw, Serono or Humegonw, Orga-
non). The starting dose was adapted according to age and ovarian
response; usually it was 150–225 IU daily and for patients with an
already known low response it was maximally 300–450 IU daily.
Ultrasound and serum estradiol measurements were performed to
assess follicular maturation; hCG (5000 to 10 000 IU, Profasiw, Ser-
ono or Pregnylw, Organon) was administered when at least three fol-
licles exceeded 17 mm in diameter and the estradiol concentration
per mature follicle exceeded 1000 pmol/l. 35–36 h after the adminis-
tration of hCG, the fluid containing the oocytes was retrieved from
all follicles by needle aspiration, with transvaginal ultrasound
guidance and under routine intravenous sedation.
Hyaluronidase denuded oocytes were assessed for maturity. Only
metaphase II oocytes, identified by the presence of the first polar
body, were chosen for fertilization. ICSI was performed 3–6 h after
oocyte recovery by using previously described techniques and
instrumentation (Tesarik and Sousa, 1995). Fertilization was
assessed 17 h after ICSI. One to two normally fertilized oocytes
(two pronuclei and two polar bodies) with the highest PN score and
with the best morphological grade were considered for embryo
transfer. Cryopreservation of the remaining PN was performed at
this stage according to the Swiss law. The fertilized oocytes selected
for transfer were cultured for another 20–30 h at 37 8C in fresh CO2
equilibrated IVF medium (Vitrolifew, Go¨teborg, Sweden). Embryo
development was evaluated 2 and 3 days after ICSI by determining
the number of blastomeres and the relative proportion of anucleate
cell fragments. Embryo scores were calculated by multiplying the
fragmentation grade (,10% fragments, grade 4; 10–20%, grade 3;
20–30%, grade 2; .30% fragments, grade 1) with the number of
blastomeres. In most cases two embryos (range 1–3) were trans-
ferred 2 or 3 days after oocyte retrieval. The Cumulated embryo
score (CES) was calculated by adding up the individual scores of
the transferred embryos for each patient.
Collection of serum and follicular fluid
Blood samples were drawn at three points: on the day of initiation
of ovarian stimulation, on the day of or one day before hCG admin-
istration, and on the day of the oocyte pick-up, withdrawn immedi-
ately before the procedure. Only cycles with an available serum
from all three time points were included in the study. Sera were pre-
pared in the central routine laboratory and stored, after the immedi-
ate determination of estradiol, at 230 8C until assayed for the other
analytes (see below) in batches.
Follicular fluid samples from individual follicles were pooled and
centrifuged for 10 min at 500 g and the supernatants were stored at
230 8C until analysed further. Fractions of FF with massive blood
contamination were excluded.
Measurement of steroid hormones, leptin and CRP in serum
and follicular fluid
Serum 17b-estradiol (E2) was assayed on the day of collection in
the routine laboratory using an automated method (‘Elecsys’,
Roche, Basle, Switzerland). Progesterone was determined by com-
petitive radio-immunoassay (RIA), using the coated tube (‘Coat-a-
Count’) kit manufactured by DPC, Los Angeles, CA, and obtained
from Buhlmann Laboratories, Basle, Switzerland. Sera, obtained at
the day of OPU, were used without dilution while the follicular
fluids were diluted 1:500 in the diluent provided, and the 3 h incu-
bation protocol was followed. Estradiol in the follicular fluids was
similarly determined with the same RIA methodology, in an 1:250
dilution and following the protocol supplied by DPC.
Leptin was quantified with an ELISA developed in our laboratory
using monoclonal ‘matched-pair’ (capture and detection) antibodies
obtained from R&D Systems, Abingdon, England. The recently
described method (Malek et al., 2001) was followed with the excep-
tion that the samples (1:50 dilution for both sera and FF) and stan-
dards (1000–15.6 pg/ml in serial 1:2 steps) were incubated in RD5P
medium (R&D Systems Europe, Abingdon, England). Subsequent
incubations were in PBS containing 0.5% non-fat milk proteins
(Blottow, Pierce USA, obtained from Socochim, Lausanne,
Switzerland) as described. The intra- and inter-assay coefficients of
variance at midstandard level (125 pg/ml) were 2.7 and 8.9%,
respectively.
CRP was determined by microplate ELISA in our laboratory as
follows: rabbit polyclonal anti-human CRP (Sigma C3527) was
added at 2mg/ml in PBS (incubation volume ¼ 100ml/well) for
overnight ‘coating’ at 4 8C, then the contents were aspirated and the
excess sites blocked with 250ml BSA (0.5% w/v in PBS) during 1 h
at 37 8C. After a washing step (two aspiration cycles using PBS con-
taining Tween-20, Sigma, 0.1% v/v), standards (CRP Sigma C4064,
100–0.39 ng/ml) or serum/FF samples (diluted in Blottoq) were
added (100ml/well) and the plates incubated for 2 h at 30 8C with a
shaking speed of 500 r.p.m. Initial sample dilution was 1:250, but it
was necessary to repeat some measurements at higher or lower
dilution. After washing the wells three times with PBST, horseradish
peroxidase conjugated rabbit anti-human CRP (Dako P227,
Glostrup, Denmark, diluted 1:10 000 in Blotto) was added and the
incubation continued for 1 h under the same conditions. Then the
wells were washed four times with PBST, and ready-to-use TMB
substrate solution (Zymed, obtained from Staehelin, Basle,
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Switzerland; 100ml/well) was added in a timed sequence. After 10–
20 min of incubation at room temperature in the dark, the reaction
was stopped by the addition of 100ml 2M hydrochloric acid in the
same sequence. The optical density was determined with a dual
channel microplate reader (Bio-Rad, Hercules, USA, model 550) at
450 nm against a reference at 590 nm. The sensitivity of the assay
was 0.30 ng/ml, but the lowest CRP concentration measured in this
study was 18 ng/ml. The intra- and inter-assay coefficients of var-
iance in the geometric mean of the standard curve were 5.54 and
10.65%, respectively (Malek et al., submitted).
Statistical methods
Concentrations of leptin, CRP and steroids between the sub-
sequently pregnant (n ¼ 47) and non-pregnant (n ¼ 102) groups
were compared non-parametrically with the Mann–Whitney U test.
The same was done, over the whole study population (n ¼ 162,
including the 13 cycles not leading to embryo transfer for reasons of
fertilization or cleavage failure, i.e. CES ¼ 0), when the concen-
trations of these markers were compared between the different time
points. Correlations between the different markers were assessed
by linear regression after logarithmic transformation and non-
parametrically by Spearman rank correlation analysis. A P-value of
0.05 or less was considered to identify a significant difference.
Results
Clinical data
Table I shows the pre-IVF treatment data and clinical par-
ameters for the two groups, those women that subsequently
became pregnant (pregnant group) and those women who did
not become pregnant (non pregnant women). The maternal
age, but not the pre-treatment FSH (assessment of ovarian
reserve) was lower in the pregnant group. The number of
retrieved oocytes at pickup and the cumulated embryo score
(CES) were significantly higher in the pregnancy group.
Steroid hormone, leptin and CRP concentrations in serum
and follicular fluids
Comparison between pregnant and non-pregnant groups
These results are given in Table II. Before the initiation of
stimulation with gonadotrophins, none of the tested markers
Table I. Pre-IVF treatment data and clinical parameters for the two groups, pregnant and non pregnant women
Clinical parameter Pregnant womena Non-pregnant womenb P-value
Maternal age (years) 31.2 ^ 4.3 33.7 ^ 3.1 ,0.001d
Body mass index (kg/m2) 23.8 ^ 3.1 23.6 ^ 3.7 0.774
Basal FSH (mIU/ml) 8.34 ^ 3.60 8.28 ^ 2.96 0.916
Oocytes retrieved 10.7 ^ 4.7 9.1 ^ 4.5 0.045
Embryos transferred 1.98 ^ 0.39 1.91 ^ 0.38 0.319
CESc 46.2 ^ 11.7 39.1 ^ 15.8 0.003d
Values given are means ^ SD (where applicable). P-values were obtained by Student’s t-test.
an ¼ 47, including 10 biochemical pregnancies and six first or second trimester abortions; the other pregnancies were
delivered and included three twin and one triplet gestation.
bn ¼ 102, excluding 13 cycles not leading to embryo transfer.
cCumulated embryo score.
dAfter Welch’s correction.
Table II. Steroid hormones, leptin (with and without correction for BMI) and CRP concentrations in serum and follicular fluid
(FF) of pregnant and non-pregnant women (for numbers and definitions see footnote to Table I)
Time point Marker Pregnant women Non-pregnant women P-value
Day 1 Leptin1 10.72 (1.48–39.39) 11.19 (1.00–45.96) 0.544
Leptin/BMI 0.39 (0.07–1.35) 0.51 (0.05–1.64) 0.445
CRP2 1.26 (0.13–35.46) 1.76 (0.12–36.99) 0.196
Estradiol3 0.071 (0.021–0.195) 0.060 (0.020–0.199) 0.162
hCG/hCG-1 Leptin1 14.08 (2.65–55.61) 16.26 (3.46–58.42) 0.493
Leptin/BMI 0.60 (0.148–2.18) 0.70 (0.166–2.58) 0.379
CRP2 1.25 (0.018–34.25) 1.40 (0.195–87.25) 0.203
Estradiol3 10.39 (2.14–24.11) 7.71 (0.97–27.87) 0.006
OPU (serum) Leptin1 15.70 (1.52–53.10) 16.86 (2.34–64.53) 0.496
Leptin/BMI 0.69 (0.080–1.87) 0.75 (0.112–2.67) 0.368
CRP2 2.87 (0.07–33.05) 3.48 (0.21–167.5) 0.481
Estradiol3 5.07 (0.37–12.39) 3.55 (0.25–81.56) 0.012
Prog.3 38.1 (7.5–102) 36.8 (8.3–1400) 0.877
OPU (FF) Leptin1 14.84 (1.23–51.00) 14.47 (1.79–55.16) 0.741
Leptin/BMI 0.65 (0.065–1.96) 0.63 (0.086–2.32) 0.630
CRP2 1.48 (0.05–51.11) 1.32 (0.11–119.3) 0.655
Estradiol3 869 (225–2335) 694 (79–3291) 0.035
Prog.4 25.2 (4.5–50.7) 29.3 (3.8 – 69.8) 0.128
Values given are medians and range; P-values were obtained by non-parametric Mann–Whitney U test (significant differences







was able to distinguish between the two groups. On the day
hCG/hCG-1 (serum) and OPU (serum and FF), estradiol was
clearly higher in the group which achieved a pregnancy com-
pared to the one who did not.
Time course of leptin and CRP concentrations during
ovarian stimulation
The serum concentrations of all markers were significantly
higher on the day of OPU than at initiation of the stimulation
phase (day 1), but the time course of this increase was differ-
ent between leptin and CRP. Levels of the former
significantly increased between day 1 of stimulation and day
hCG-1/hCG, but did not anymore between then and the day
of OPU. This was comparable to estradiol whose levels
behaved similarly, but with a decrease between the day of
hCG-1/hCG and OPU. On the other hand, CRP did not show
an increase between day 1 and day hCG-1/hCG, but its
serum levels doubled in the 72/48 h time interval between
then and OPU. When the hCG-1 and hCG time points were
compared and analysed separately (n ¼ 70 and 92, respect-
ively), leptin was found to significantly increase during this
24 h interval while estradiol had already ceased doing so and
CRP was beginning to rise but not with statistical signifi-
cance yet. The results of these longitudinal investigations are
illustrated in Figure 1. In contrast to estradiol and progester-
one with their respectively 200- and 600-fold increase over
the serum level on the day of OPU, the follicular fluid con-
centrations of leptin and CRP were lower than in the serum.
This reduction in FF level was significant for CRP but not
for leptin (Figure 1).
Correlations between leptin and CRP levels, and with
gonadal steroids and clinical parameters
On the day of OPU, an extremely high significance level
(P , 0.0001) was found for the correlation with the body
mass index not only for leptin, but also for CRP in the serum
(Figure 2A) and in the follicular fluid (Figure 2B). Similarly
to leptin, the CRP concentrations were in strong correlation
between the two compartments (r ¼ 0.897, Figure 2C). A
strong positive association was also observed between CRP
and leptin in the serum as well as in the follicular fluid
(P , 0.0001, both compartments, Spearman Rank correlation).
Figure 1. Box and whisker plot of estradiol, leptin and CRP levels
in serum as a function of the stimulation phase, and in follicular
fluid. Boxes represent the median (central line) and quartiles; whis-
kers show the minima and maxima. Two outliers are shown as
single closed squares. Note the logarithmic scale. Statistically sig-
nificant differences (P , 0.05 by Mann–Whitney analysis) between
neighbouring groups are illustrated with a bracket and asterisk. Day
‘hCG-1’ ¼ 3 days before OPU; day ‘hCG’ ¼ 2 days before OPU.
Figure 2. CRP levels on the day of OPU. Correlation between CRP in the serum (Figure 2A, closed circles) or in the follicular fluid (Figure
2B, open circles) and the body mass index (BMI). These associations are highly significant (P , 0.0001). Figure 2C compares the CRP levels
between serum and follicular fluid. Closed circles, pregnant (n ¼ 47); open circles, not pregnant (n ¼ 115).
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On the other hand, no correlations were observed between the
gonadal steroids (estradiol or progesterone) and leptin or CRP
in the serum or in the follicular fluid (all P . 0.31). This was
also the case when leptin and CRP levels were used as a ratio
between the concentration of the protein and the body mass
index of the patient (all P . 0.12).
Discussion
There is not yet much information on CRP in IVF treatment
and it is interesting that, to date, there does not seem to be a
consensus between the few different studies. In this respect,
the considerable differences in the number of patients
included have to be noted, ranging from 16 in the paper from
Orvieto et al. (2004a) to ten times this number in our study.
In agreement to several other studies (Mendall et al., 1996;
Ford, 1999; Visser et al., 1999; Yudkin et al., 1999), we
have found a positive correlation between CRP and BMI. In
the other study on CRP relating to IVF (Almagor et al.,
2004), data on BMI were not given. In contrast to Orvieto
et al. (2004a), we also found a significant (P , 0.001) differ-
ence in CRP levels between follicular fluid and serum taken
on the day of OPU, with the FF concentration being lower.
We believe that, for both observations comparing our study
with the one cited (Orvieto et al., 2004a), statistical signifi-
cance was reached in ours because of the higher number of
cases included, since the trend was the same and the range of
measured values was wide.
Our results concur with the other studies (Almagor et al.,
2004; Orvieto et al., 2004a) showing no difference in serum
CRP levels on the day of ovarian pick-up (OPU) between
women subsequently becoming pregnant and those who did
not. Leptin was also found not to be a prognostic marker in
this context, which is however in contrast to others who did
observe lower leptin levels to be associated with treatment
success (Mantzoros et al., 2000; Tsai et al., 2002). In our
study the estradiol concentration was the only prognostic par-
ameter that was increased in the serum (as well as in the fol-
licular fluid.) without a lot of women who became pregnant
over those who did not on the day of hCG administration or
hCG-1 and at OPU.
We could confirm the association of CRP and leptin levels
found by others (Maruna et al., 2001; Shamsuzzaman et al.,
2004), and we concur with the findings of Orvieto et al.
(2004a) who did not find any correlations between steroid
hormones and CRP or between steroid hormones and leptin.
Our findings are also in full agreement with the recently pub-
lished study by Chen et al. (2004), with an absence of corre-
lation between serum or follicular fluid leptin levels and
gonadal steroid levels or IVF outcome. Regarding CRP, our
results as well as the findings by Orvieto et al. (2004a)
showed a significant increase in concentration on day of
OPU when compared to the day hCG/-1 in spite of the
decrease in E2 levels at this stage.
To our knowledge no data comparing CRP with leptin and
steroids in this field are available in the literature. Our study
is therefore unique since we have demonstrated that leptin
and CRP, which are both involved in inflammatory processes,
showed a significant difference in their serum concentration
time course during ovarian stimulation. In contrast to leptin
levels, which continually rose during the ovarian stimulation
phase until the day of hCG/hCG-1, the concentrations of
CRP did not change between the first day of stimulation and
the day of hCG/hCG-1. This latter finding is in contrast to
the one by Orvieto et al. (2004a) who reported a significant
increase in serum CRP levels during stimulation and con-
cluded that the controlled ovarian hyperstimulation poten-
tiated a state of systemic inflammation. But our observations
are in line with the recent report by Orvieto (2004b) where
he described a significant increase in CRP level on the day of
ovum pick-up compared to the day of hCG adminstration
despite the decrease in E2 level, and where he speculated
that the inflammatory response was significantly stimulated
by the exogeneous hCG. Orvieto et al. also reported on
another inflammatory marker, leukocyte selectin (L-selectin),
which was even found to be decreased during controlled
ovarian hyperstimulation until peak estradiol was reached,
and then significantly increased after hCG administration
(Orvieto et al., 2001). It seems that the situation is quite
complex. An explanation for the discrepancies in the time
course of the two inflammatory mediators leptin and CRP
could be that they might be unrelated to each other or that
they follow different pathways in the inflammatory process.
It has to be noted that blood sampling for measuring CRP
and leptin was obtained before oocyte collection was started,
and thus no ovulation or stress induction had taken place.
Moreover, the lower CRP concentration in the FF than in the
serum is indicating an absent or very low production of this
protein in the ovary, and there are no data on in vitro CRP
production by granulosa cells in the literature.
Conclusions
In conclusion, we could show that ovulation induction is an
inflammatory process leading to increased levels of CRP as
well as of leptin, but with different patterns. However,
according to our study results, they cannot be used as mar-
kers of successful outcome of the IVF treatment.
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